HC Wainwright reiterated coverage on BioLineRx with a new price target

3/1/21 8:36:34 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright reiterated coverage of BioLineRx with a rating of Buy and set a new price target of $19.00 from $22.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BLRX

Date	Price Target	Rating	Analyst